Screener
Galectin Therapeutics GALT Q1 2025 Annual earnings
Reported May 15, 2025 · Before market open
EPS-$0.15Beat by $0.05
EPS estimate-$0.20
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.05
Versus estimates
Diluted EPS
FAQ
- When did Galectin Therapeutics report Q1 2025 earnings?
- Galectin Therapeutics (GALT) reported Q1 2025 earnings on May 15, 2025 before market open.
- What were Galectin Therapeutics's Q1 2025 revenue and EPS?
- Galectin Therapeutics reported eps of $-0.15 for Q1 2025.
- Did Galectin Therapeutics beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.20 by $0.05.
- How did Galectin Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 21.1% from $-0.19.
- Where can I find Galectin Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001140361-25-018277) and the 10-K periodic report (0001140361-25-011169) directly on SEC EDGAR. The filing index links above go to sec.gov.
